Skip to content

Study · In vitro (cells) · chinese hamster · 2006

7 results

Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cells.

Galbraith DJ, Tait AS, Racher AJ, Birch JR, James DC

Biotechnology progress1 May 2006Cited by 57 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study7

3 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Other

    In CHO cell cultures, adding recombinant LR3-IGF increased monoclonal antibody product titer 2-fold.

    In plain wordsIn cells, adding LR3-IGF to hamster cell cultures raised antibody yield 2-fold.

    Peptide
    IGF-1 LR3
    Outcome
    IncreaseMonoclonal antibody product titer with LR3-IGF alone
    Study

    Chinese hamstern: not reported in source

    CHO cells, PEI-mediated transient transfection
    Outcome group
    Synthesis and manufacturing · Pharmacology
    Studied dose
    Dose not stated

    Measurements

    Product titer increase
    2-fold
    LR3-IGF alone

    Source sentences

    Summary
    Separately, both addition of recombinant insulin-like growth factor (LR3-IGF) and a reduction in culture temperature to 32 degrees C were found to increase product titer 2- and 3-fold, respectively.
    1 context sentence
    Summary · context
    In this study we describe optimization of polyethylenimine (PEI)-mediated transient production of recombinant protein by CHO cells by facile manipulation of a chemically defined culture environment to limit accumulation of nonproductive cell biomass, increase the duration of recombinant protein prod…
  2. 02LabIn vitro (cells)Other

    In CHO cell cultures, LR3-IGF and mild hypothermia acted synergistically to increase product titer 11-fold.

    In plain wordsIn cells, LR3-IGF and a cooler culture temperature raised antibody yield 11-fold.

    Peptide
    IGF-1 LR3
    Outcome
    IncreaseMonoclonal antibody product titer with LR3-IGF plus mild hypothermia
    Study

    Chinese hamstern: not reported in source

    CHO cells, PEI-mediated transient transfection
    Outcome group
    Synthesis and manufacturing · Pharmacology
    Studied dose
    Dose not stated

    Measurements

    Product titer increase
    11-fold
    LR3-IGF plus 32 degrees C

    Source sentences

    Summary
    However, mild hypothermia and LR3-IGF acted synergistically to increase product titer 11-fold.
    1 context sentence
    Summary · context
    In this study we describe optimization of polyethylenimine (PEI)-mediated transient production of recombinant protein by CHO cells by facile manipulation of a chemically defined culture environment to limit accumulation of nonproductive cell biomass, increase the duration of recombinant protein prod…
  3. 03LabIn vitro (cells)Mechanism

    In CHO cell cultures, the higher product titer with LR3-IGF alone was solely a consequence of increased culture duration.

    In plain wordsIn cells, LR3-IGF raised antibody yield only because the cultures lasted longer.

    Peptide
    IGF-1 LR3
    Outcome
    IncreaseCulture duration with LR3-IGF alone
    Study

    Chinese hamstern: not reported in source

    CHO cells, PEI-mediated transient transfection
    Outcome group
    Synthesis and manufacturing · Pharmacology
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Although increased product titer in the presence of LR3-IGF alone was solely a consequence of increased culture duration
    1 context sentence
    Summary · context
    In this study we describe optimization of polyethylenimine (PEI)-mediated transient production of recombinant protein by CHO cells by facile manipulation of a chemically defined culture environment to limit accumulation of nonproductive cell biomass, increase the duration of recombinant protein prod…

Studies that did not test the peptide alone4

In this study, IGF-1 LR3 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking IGF-1 LR3.

  1. 04LabNot a test of IGF-1 LR3 aloneIn vitro (cells)Other

    In CHO cultures kept at 32 degrees C with LR3-IGF, the integral of viable cell concentration increased 4-fold.

    In plain wordsIn cells, cooler cultures with LR3-IGF had 4 times the integral of viable cell concentration.

    Peptide
    IGF-1 LR3
    Outcome
    IncreaseIntegral of viable cell concentration with LR3-IGF at 32 degrees C
    Study

    Chinese hamstern: not reported in source

    CHO cells, PEI-mediated transient transfection
    Outcome group
    Synthesis and manufacturing · Pharmacology

    Measurements

    IVC increase
    4-fold
    32 degrees C with LR3-IGF

    Source sentences

    Summary
    For cultures maintained at 32 degrees C in the presence of LR3-IGF, IVC and qMab were increased 4- and 2.5-fold, respectively.
    1 context sentence
    Summary · context
    In this study we describe optimization of polyethylenimine (PEI)-mediated transient production of recombinant protein by CHO cells by facile manipulation of a chemically defined culture environment to limit accumulation of nonproductive cell biomass, increase the duration of recombinant protein prod…

    In this study, IGF-1 LR3 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking IGF-1 LR3.

  2. 05LabNot a test of IGF-1 LR3 aloneIn vitro (cells)Other

    In CHO cultures kept at 32 degrees C with LR3-IGF, the cell-specific Mab production rate (qMab) increased 2.5-fold.

    In plain wordsIn cells, cooler cultures with LR3-IGF made 2.5 times more antibody per cell.

    Peptide
    IGF-1 LR3
    Outcome
    IncreaseCell-specific Mab production rate with LR3-IGF at 32 degrees C
    Study

    Chinese hamstern: not reported in source

    CHO cells, PEI-mediated transient transfection
    Outcome group
    Synthesis and manufacturing · Pharmacology

    Measurements

    qMab increase
    2.5-fold
    32 degrees C with LR3-IGF

    Source sentences

    Summary
    For cultures maintained at 32 degrees C in the presence of LR3-IGF, IVC and qMab were increased 4- and 2.5-fold, respectively.
    1 context sentence
    Summary · context
    In this study we describe optimization of polyethylenimine (PEI)-mediated transient production of recombinant protein by CHO cells by facile manipulation of a chemically defined culture environment to limit accumulation of nonproductive cell biomass, increase the duration of recombinant protein prod…

    In this study, IGF-1 LR3 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking IGF-1 LR3.

  3. 06LabNot a test of IGF-1 LR3 aloneIn vitro (cells)Other

    In CHO cultures kept at 32 degrees C with LR3-IGF, periodic resuspension of transfected cells in fresh media gave a 3-fold increase in accumulated Mab titer, from about 13 to about 39 mg L(-1).

    In plain wordsIn cells, moving transfected cells into fresh media from time to time raised antibody yield 3-fold.

    Peptide
    IGF-1 LR3
    Outcome
    IncreaseAccumulated Mab titer with periodic resuspension in fresh media
    Study

    Chinese hamstern: not reported in source

    CHO cells, PEI-mediated transient transfection
    Outcome group
    Synthesis and manufacturing · Pharmacology

    Measurements

    Accumulated Mab titer increase
    3-fold
    periodic resuspension
    Accumulated Mab titer start
    ≈ 13 mg L(-1)
    periodic resuspension
    Accumulated Mab titer end
    ≈ 39 mg L(-1)
    periodic resuspension

    Source sentences

    Summary
    To further increase product yield from transfected DNA, the duration of transgene expression in cell populations maintained at 32 degrees C in the presence of LR3-IGF was doubled by periodic resuspension of transfected cells in fresh media, leading to a 3-fold increase in accumulated Mab titer from…
    1 context sentence
    Summary · context
    In this study we describe optimization of polyethylenimine (PEI)-mediated transient production of recombinant protein by CHO cells by facile manipulation of a chemically defined culture environment to limit accumulation of nonproductive cell biomass, increase the duration of recombinant protein prod…

    In this study, IGF-1 LR3 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking IGF-1 LR3.

  4. 07LabNot a test of IGF-1 LR3 aloneIn vitro (cells)Other

    In CHO cultures with LR3-IGF at 32 degrees C, Mab glycosylation at Asn297 stayed essentially constant and was similar to that of Mab from stably transfected GS-CHO cells.

    In plain wordsIn cells, the antibody sugar pattern at Asn297 did not change and matched that of antibody from stably transfected cells.

    Peptide
    IGF-1 LR3
    Outcome
    No significant changeMab glycosylation at Asn297
    Study

    Chinese hamstern: not reported in source

    CHO cells, PEI-mediated transient transfection
    Comparator
    Mab from stably transfected GS-CHO cells
    Outcome group
    Synthesis and manufacturing · Pharmacology

    Source sentences

    Summary
    Under these conditions, Mab glycosylation at Asn297 remained essentially constant and similar to that of the same Mab produced by stably transfected GS-CHO cells.
    1 context sentence
    Summary · context
    In this study we describe optimization of polyethylenimine (PEI)-mediated transient production of recombinant protein by CHO cells by facile manipulation of a chemically defined culture environment to limit accumulation of nonproductive cell biomass, increase the duration of recombinant protein prod…

    In this study, IGF-1 LR3 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking IGF-1 LR3.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.